SS Innovations International (SSII) Profit After Tax Growth (3y) (2019 - 2026)
SS Innovations International (SSII) Profit After Tax Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -6.51% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 7.96% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 2.68% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 62.16% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 3.79% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 60.12% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 2.38% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 30.83% |
| 10 | SS Innovations International | 776.19 Mn | 752.58 Mn | 5.33 Mn | -38.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -38.20% |
| Dec 31, 2025 | 11.29% |
| Sep 30, 2025 | -105.16% |
| Jun 30, 2025 | 22.31% |
| Mar 31, 2025 | -312.84% |
| Dec 31, 2024 | -71.32% |
| Sep 30, 2024 | 47.35% |
| Jun 30, 2024 | -115.97% |
| Mar 31, 2024 | -220.87% |
| Dec 31, 2023 | -279.68% |
| Sep 30, 2023 | -75.59% |
| Jun 30, 2023 | -193.05% |
| Mar 31, 2023 | -64.13% |
| Dec 31, 2022 | 0.82% |
| Sep 30, 2022 | 29.66% |
| Jun 30, 2022 | -11.74% |
| Mar 31, 2022 | 41.19% |
| Dec 31, 2021 | -17.31% |
| Sep 30, 2021 | -12.05% |
| Jun 30, 2021 | -26.12% |